Adam Freund

Company: Arda Therapeutics

Job title: CEO

Seminars:

Exploring ADC-Mediated Depletion of Pathogenic Fibroblasts as a Therapeutic Strategy for Fibrosis 9:00 am

Highlighting the use of single-cell-based target discovery engines to identify and target specific pathogenic sub-populations of fibroblasts Examining the precision and specificity of identifying and targeting fibroblast subsets that drive fibrosis with antibody-drug conjugates Evaluating the effectiveness of these biologics in preclinical models of various fibrotic diseases, focusing on their sensitivity, specificity, and impact on…Read more

day: Day Two